Modification of buccal drug delivery following pretreatment with skin penetration enhancers

Journal of Pharmaceutical Sciences

Volumn 93, Issue 8, 2004, Pages 2054-2063

  Nicolazzo, Joseph A ^a   Reed, Barry L ^a   Finnin, Barrie C ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Buccal mucosa; Caffeine; Drug permeability; Estradiol; Partition coefficient; Penetration enhancers; Tissue retention; Triamcinolone acetonide

Indexed keywords

ALCOHOL; BOVINE SERUM ALBUMIN; CAFFEINE; ESTRADIOL; LAUROCAPRAM; OCTISALATE; PADIMATE; SUNSCREEN; TRIAMCINOLONE ACETONIDE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CHEEK MUCOSA; DRUG DELIVERY SYSTEM; DRUG MANUFACTURE; IN VITRO STUDY; LIPOPHILICITY; MODEL; NONHUMAN; PARTITION COEFFICIENT; SKIN PENETRATION;

EID: 3843104844     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1002/jps.20113     Document Type: Article

References (32)

1. Gandhi R, Robinson J. 1992. Mechanisms of penetration enhancement for transbuccal delivery of salicylic acid. Int J Pharm 85:129-140.
2. Deneer VHM, Drese GB, Roemelé PEH, Verhoef JC, Lie-A-Huen L, Kingma JH, Brouwers JRBJ, Junginger HE. 2002. Buccal transport of flecainide and sotalol: Effect of a bile salt and ionization state. Int J Pharm 241:127-134.
3. Ganem-Quintanar A, Quintanar-Guerrero D, Falson-Rieg F, Buri P. 1998. Ex vivo oral mucosal permeation of lidocaine hydrochloride with sucrose fatty acid esters as absorption enhancers. Int J Pharm 173:203-210.
4. Hoogstraate AJ, Verhoef JC, Pijpers A, van Leengoed LAMG, Verheijden JHM, Junginger HE, Boddé HE. 1996. In vivo buccal delivery of the peptide drug buserelin with glycodeoxycholate as an absorption enhancer in pigs. Pharm Res 13: 1233-1237.
5. Ganem-Quintanar A, Kalia YN, Falson-Reig F, Buri P. 1997. Mechanisms of oral permeation enhancement. Int J Pharm 156:127-142.
6. Morgan TM, Reed BL, Finnin BC. 1998. Enhanced skin permeation of sex hormones with novel topical spray vehicles. J Pharm Sci 87:1213-1218.
7. Morgan TM, O'Sullivan HM, Reed BL, Finnin BC. 1998. Transdermal delivery of estradiol in postmenopausal women with a novel topical aerosol. J Pharm Sci 87:1226-1228.
8. Morgan TM, Parr RA, Reed BL, Finnin BC. 1998. Enhanced transdermal delivery of sex hormones in swine with a novel topical aerosol. J Pharm Sci 87:1219-1225.
9. DeSimone EM. 1994. FDA proposes changes in sunscreen regulations. Am Pharm NS34:26-31.
10. Lesch CA, Squier CA, Cruchley A, Williams DM, Speight P. 1989. The permeability of human oral mucosa and skin to water. J Dent Res 68:1345-1349.
11. Nicolazzo JA, Reed BL, Finnin BC. 2003. The effect of various in vitro conditions on the permeability characteristics of the buccal mucosa. J Pharm Sci 92:2399-2410.
12. Yamashita S, Furubayashi T, Kataoka M, Sakane T, Sezaki H, Tokuda H. 2000. Optimized conditions for prediction of intestinal drug permeability using Caco-2 cells. Eur J Pharm Sci 10:195-204.
13. Aungst BJ, Nguyen NH, Bulgarelli JP, Oates-Lenz K. 2000. The influence of donor and reservoir additives on Caco-2 permeability and secretory transport of HIV protease inhibitors and other lipophilic compounds. Pharm Res 17:1175-1180.
14. Saha P, Kou JH. 2002. Effect of bovine serum albumin on drug permeability estimation across Caco-2 monolayers. Eur J Pharm Biopharm 54:319-324.
15. Sansom L, editor. 1997. Australian pharmaceutical formulary and handbook, vol. 16. Canberra: Pharmaceutical Society of Australia, p 96.
16. Howie NM, Trigkas TK, Cruchley AT, Wertz PW, Squier CA, Williams DM. 2001. Short-term exposure to alcohol increases the permeability of human oral mucosa. Oral Dis 7:349-354.
17. Du X, Squier CA, Kremer MJ, Wertz PW. 2000. Penetration of N-nitrosonornicotine (NNN) across oral mucosa in the presence of ethanol and nicotine. J Oral Pathol Med 29:80-85.
18. Squier CA, Cox P, Hall BK. 1986. Enhanced penetration of nitrosonornicotine across oral mucosa in the presence of ethanol. J Oral Pathol 15:276-279.
19. R on the in vitro percutaneous penetration of compounds with different lipophilicities. Int J Pharm 202:133-140.
20. Barry BW. 1987. Mode of action of penetration enhancers in human skin. J Controlled Release 6:85-97.
21. Kurosaki Y, Hisaichi SI, Hong LZ, Nakayama T, Kimura T. 1989. Enhanced permeability of keratinized oral-mucosa to salicylic acid with 1-dodecylazacycloheptan-2-one (Azone): In vitro studies in hamster cheek pouch. Int J Pharm 49:47-55.
22. Kurosaki Y, Hisaichi S, Nakayama T, Kimura T. 1989. Enhancing effect of 1-dodecylazacycloheptan-2-one (Azone) on the absorption of salicylic acid from keratinized oral mucosa and the duration of enhancement in vivo. Int J Pharm 51:47-54.
23. Squier CA, Wertz PW. 1996. Structure and function of the oral mucosa and implications for drug delivery. In: Rathbone MJ, editor. Oral mucosal drug delivery. New York: Marcel Dekker Inc., p 1-26.
24. Dong BJ. 2002. Female sex hormones. In: Anderson PO, Knoben JE, Troutman WG, editors. Handbook of clinical drug data. New York: McGraw-Hill, pp 679-697.
25. Beckett AH, Triggs EJ. 1967. Buccal absorption of basic drugs and its application as an in vivo model of passive drug transfer through lipid membranes. J Pharm Pharmacol 19:31S-41S.
26. Beckett AH, Pickup ME. 1975. A model for steroid transport across biological membranes. J Pharm Pharmacol 27:226-234.
27. Davis BJ, Johnston A. 1979. Buccal absorption of verapamil - Evidence for membrane storage. Br J Clin Pharmacol 65:434P.
28. Henry JA, Ohashi K, Wadsworth J, Turner P. 1980. Drug recovery following buccal absorption of propranolol. Br J Clin Pharmacol 10:61-65.
29. Kremer MJ, Squier CA, Wertz PW. 1997. Absorption and release of topical triamcinolone in oral mucosa. J Dent Res 76:361.
30. Squier CA, Kremer MJ, Bruskin A, Rose A, Haley JD. 1999. Oral mucosal permeability and stability of transforming growth factor beta-3 in vitro. Pharm Res 16:1567-1563.
31. Chow DS-L, Kaka I, Wang TI. 1984. Concentration-dependent enhancement of 1-dodecylazacycloheptan-2-one on the percutaneous penetration kinetics of triamcinolone acetonide. J Pharm Sci 73:1794-1799.
32. Phillips CA, Michniak BB. 1995. Transdermal delivery of drugs with differing lipophilicities using Azone analogs as dermal penetration enhancers. J Pharm Sci 84:1427-1433.